|
Volumn 161, Issue 2, 2004, Pages 370-372
|
Response to Tricyclic Antidepressants: Independent of Gender?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADULT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
GENDER;
HAMILTON SCALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE REGRESSION;
PRIORITY JOURNAL;
REVIEW;
TREATMENT OUTCOME;
ARTICLE;
HOSPITALIZATION;
MAJOR DEPRESSION;
MARKETING;
RANDOMIZED CONTROLLED TRIAL;
SEX DIFFERENCE;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
DEPRESSIVE DISORDER, MAJOR;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MARKETING;
SEVERITY OF ILLNESS INDEX;
SEX FACTORS;
|
EID: 1642527862
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.161.2.370 Document Type: Review |
Times cited : (51)
|
References (6)
|